Dive deeper with STAT+. Gain unlimited access to expert analysis, newsletters, events, and news alerts.

The FDA has approved Sisnos’s continuous glucose monitoring (CGM) system for consumer use beyond diabetes management, ...

Palo Alto, California-based Signos integrated the Dexcom Stelo OTC continuous glucose monitor (CGM) with an AI-powered ...

The Signos Glucose Monitoring System is a mobile device application that receives data from an OTC integrated continuous ...

Any patient can access Signos' system, which uses an AI platform and an off-the-shelf continuous glucose monitor, or CGM, ...

The FDA approved the first over-the-counter glucose monitoring system designed to help with weight management. Developed by health technology company Signos, the system combines the Stelo by Dexcom ...

The FDA cleared the first glucose monitoring system specifically designed for weight management from Signos, providing a new ...

Signos Inc. landed U.S. FDA clearance for its over-the-counter glucose monitoring system, which combines Dexcom Inc.'s ...

Signos’s glucose-tracking system uses AI and real-time data to guide healthier habits—no prescription required.

The FDA on Wednesday approved the first-ever glucose monitoring system specifically for weight loss from the startup Signos, establishing a new option for Americans to manage their weight. The Signos ...